Novartis’ Sandoz introduces generic version of Teva’s multiple sclerosis drug

Novartis subsidiary Sandoz has introduced Glatopa in the US, a generic version of Teva's Copaxone (glatiramer acetate injection) 20mg/ml one-time-daily multiple sclerosis (MS) therapy.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news